ODE-512

TREATMENT OF CYSTIC FIBROSIS (CF) IN PATIENTS AGED 2 YEARS AND OLDER WHO HAVE ONE OF THE ADDITIONAL MUTATIONS IN THE CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE THAT IS RESPONSIVE BASED ON CLINICAL AND/OR IN VITRO DATA AND IDENTIFIED I